Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    August 2019
  1. BEECH H
    Expression of concern: Hepatitis C virus activates interleukin-1beta via caspase-1-inflammasome complex.
    J Gen Virol. 2019 Aug 23. doi: 10.1099/jgv.0.001313.
    PubMed     Text format    


  2. BEECH H
    Expression of concern: Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway.
    J Gen Virol. 2019 Aug 20. doi: 10.1099/jgv.0.001312.
    PubMed     Text format    


    June 2019
  3. OSAWA M, Uchida T, Imamura M, Teraoka Y, et al
    Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice.
    J Gen Virol. 2019 Jun 14. doi: 10.1099/jgv.0.001268.
    PubMed     Text format     Abstract available


    May 2019
  4. SHUI J, Liu W, Liang Y, Zhang J, et al
    Infection of human pegivirus 2 (HPgV-2) is associated with hepatitis C virus but not hepatitis B virus infection in people who inject drugs.
    J Gen Virol. 2019 May 15. doi: 10.1099/jgv.0.001266.
    PubMed     Text format     Abstract available


    January 2019
  5. BERNIER A, Sagan SM
    Beyond sites 1 and 2, miR-122 target sites in the HCV genome have negligible contributions to HCV RNA accumulation in cell culture.
    J Gen Virol. 2019 Jan 17. doi: 10.1099/jgv.0.001217.
    PubMed     Text format     Abstract available


  6. BUKOWSKA-OSKO I, Perlejewski K, Caraballo Cortes K, Pollak A, et al
    Corrigendum: Next-generation Sequencing Analysis of New Genotypes Appearing During Antiviral Treatment of Chronic Hepatitis C Reveals that These Are Selected from Pre-existing Minor Strains.
    J Gen Virol. 2019 Jan 11. doi: 10.1099/jgv.0.001225.
    PubMed     Text format    


    December 2018
  7. ZHANG Y, Zou J, Zhao X, Yuan Z, et al
    Hepatitis C virus NS5A inhibitor daclatasvir allosterically impairs NS4B-involved protein-protein interactions within the viral replicase and disrupts the replicase quaternary structure in a replicase assembly surrogate system.
    J Gen Virol. 2018 Dec 5. doi: 10.1099/jgv.0.001180.
    PubMed     Text format     Abstract available


    November 2018
  8. GAMBATO M, Gregori J, Quer J, Koutsoudakis G, et al
    Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation.
    J Gen Virol. 2018 Nov 19. doi: 10.1099/jgv.0.001175.
    PubMed     Text format     Abstract available


  9. IWONA BO, Karol P, Kamila CC, Pollak A, et al
    Next-generation sequencing analysis of new genotypes appearing during antiviral treatment of chronic hepatitis C reveals that these are selected from pre-existing minor strains.
    J Gen Virol. 2018 Nov 5. doi: 10.1099/jgv.0.001160.
    PubMed     Text format     Abstract available


    October 2018
  10. MORI H, Fukuhara T, Ono C, Tamura T, et al
    Induction of selective autophagy in cells replicating hepatitis C virus genome.
    J Gen Virol. 2018 Oct 12. doi: 10.1099/jgv.0.001161.
    PubMed     Text format     Abstract available


    July 2018
  11. SHIRASAGO Y, Fukazawa H, Aizaki H, Suzuki T, et al
    Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
    J Gen Virol. 2018 Jul 25. doi: 10.1099/jgv.0.001117.
    PubMed     Text format     Abstract available


  12. DA SILVA MS, Junqueira DM, Baumbach LF, Cibulski SP, et al
    Comprehensive evolutionary and phylogenetic analysis of Hepacivirus N (HNV).
    J Gen Virol. 2018;99:890-896.
    PubMed     Text format     Abstract available


    June 2018
  13. MEJER N, Fahnoe U, Galli A, Ramirez S, et al
    Ribavirin-induced mutagenesis across the complete open reading frame of hepatitis C virus genotypes 1a and 3a.
    J Gen Virol. 2018 Jun 21. doi: 10.1099/jgv.0.001095.
    PubMed     Text format     Abstract available


    January 2018
  14. BELDAR S, Manimekalai MSS, Cho NJ, Baek K, et al
    Self-association and conformational variation of NS5A domain 1 of hepatitis C virus.
    J Gen Virol. 2018 Jan 4. doi: 10.1099/jgv.0.001000.
    PubMed     Text format     Abstract available


    December 2017
  15. ORDEIG L, Garcia-Cehic D, Gregori J, Soria ME, et al
    New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors.
    J Gen Virol. 2017 Dec 14. doi: 10.1099/jgv.0.000996.
    PubMed     Text format     Abstract available


  16. LI Z, Liu Q
    Proprotein convertase subtilisin/kexin type 9 inhibits hepatitis C virus replication through interacting with NS5A.
    J Gen Virol. 2017 Dec 13. doi: 10.1099/jgv.0.000987.
    PubMed     Text format     Abstract available


  17. RADKOWSKI M, Opoka-Kegler J, Cortes KC, Bukowska-Osko I, et al
    Corrigendum: Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin.
    J Gen Virol. 2017;98:3122.
    PubMed     Text format    


    November 2017
  18. GOONAWARDANE N, Ross-Thriepland D, Harris M
    Regulation of hepatitis C virus replication via threonine phosphorylation of the NS5A protein.
    J Gen Virol. 2017 Nov 15. doi: 10.1099/jgv.0.000975.
    PubMed     Text format     Abstract available


    October 2017
  19. KELLY L, Badhan A, Roberts GC, Mbisa JL, et al
    Manipulation of both virus- and cell-specific factors is required for robust transient replication of a hepatitis C virus genotype 3a sub-genomic replicon.
    J Gen Virol. 2017 Oct 6. doi: 10.1099/jgv.0.000932.
    PubMed     Text format     Abstract available


    August 2017
  20. YANG CH, Li HC, Ku TS, Wu PC, et al
    Hepatitis C virus down-regulates SERPINE1/PAI-1 expression to facilitate its replication.
    J Gen Virol. 2017 Aug 31. doi: 10.1099/jgv.0.000901.
    PubMed     Text format     Abstract available


    July 2017
  21. FENG Y, Feng YM, Lu C, Han Y, et al
    Tree shrew, a potential animal model for hepatitis C, supports the infection and replication of HCV in vitro and in vivo.
    J Gen Virol. 2017 Jul 31. doi: 10.1099/jgv.0.000869.
    PubMed     Text format     Abstract available


  22. MANUYLOV VA, Chub EV, Kichatova VS, Soboleva NV, et al
    Hepatitis C virus subtype 3a was introduced in the USSR in the early 1980s.
    J Gen Virol. 2017 Jul 26. doi: 10.1099/jgv.0.000878.
    PubMed     Text format     Abstract available


  23. GRIGOROV B, Molle J, Rubinstein E, Zoulim F, et al
    CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000850.
    PubMed     Text format     Abstract available


  24. KASSELA K, Karakasiliotis I, Charpantidis S, Koskinas J, et al
    High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis.
    J Gen Virol. 2017 Jul 15. doi: 10.1099/jgv.0.000851.
    PubMed     Text format     Abstract available


  25. CAMPOS GRF, Bittar C, Jardim ACG, Shimizu JF, et al
    Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
    J Gen Virol. 2017 Jul 12. doi: 10.1099/jgv.0.000808.
    PubMed     Text format     Abstract available


  26. YI Z, Yuan Z
    Aggregation of a hepatitis C virus replicase module induced by ablation of p97/VCP.
    J Gen Virol. 2017 Jul 10. doi: 10.1099/jgv.0.000828.
    PubMed     Text format     Abstract available


    June 2017
  27. HULLEGIE SJ, Arends JEA, Groothuismink ZMA, Pas SD, et al
    Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients.
    J Gen Virol. 2017 Jun 8. doi: 10.1099/jgv.0.000768.
    PubMed     Text format     Abstract available


    May 2017
  28. RAJ M, Langley M, McArthur SJ, Jean F, et al
    Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells.
    J Gen Virol. 2017 May 26. doi: 10.1099/jgv.0.000754.
    PubMed     Text format     Abstract available


    February 2017
  29. DAS S, Mullick R, Kumar A, Tandon H, et al
    Identification of a novel epitope in the C-terminus of HCV-E2 protein that induces potent and cross-reactive neutralizing antibodies.
    J Gen Virol. 2017 Feb 3. doi: 10.1099/jgv.0.000735.
    PubMed     Text format     Abstract available


  30. NAIK AS, Palmer BA, Crosbie O, Kenny-Walsh E, et al
    Humoral immune system targets clonotypic antibody-associated hepatitis C virus.
    J Gen Virol. 2017;98:179-189.
    PubMed     Text format     Abstract available


    January 2017
  31. UCHIDA T, Imamura M, Kan H, Hiraga N, et al
    Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
    J Gen Virol. 2017 Jan 28. doi: 10.1099/jgv.0.000726.
    PubMed     Text format     Abstract available


  32. VENTURA M, Martin L, Jaubert C, Andreola ML, et al
    HCV intragenomic interactions are modulated by the SLVI RNA structure of the core coding sequence.
    J Gen Virol. 2017 Jan 27. doi: 10.1099/jgv.0.000719.
    PubMed     Text format     Abstract available


    December 2016
  33. NIEDER-ROHRMANN A, Dunnes N, Gerresheim GK, Shalamova LA, et al
    Cooperative enhancement of translation by two adjacent microRNA-122/Argonaute 2 complexes binding to the 5 untranslated region of Hepatitis C Virus RNA.
    J Gen Virol. 2016 Dec 23. doi: 10.1099/jgv.0.000697.
    PubMed     Text format     Abstract available


  34. FLETCHER N, Clark AR, Balfe P, McKeating J, et al
    TNF superfamily members promote hepatitis C virus entry via an NF-kappaB and myosin light chain kinase dependent pathway.
    J Gen Virol. 2016 Dec 15. doi: 10.1099/jgv.0.000689.
    PubMed     Text format     Abstract available


    November 2016
  35. NAIK AS, Palmer BA, Crossbie O, Kenny-Walsh E, et al
    Humoral immune system targets clonotypic antibody associated Hepatitis C Virus.
    J Gen Virol. 2016 Nov 14. doi: 10.1099/jgv.0.000659.
    PubMed     Text format     Abstract available


  36. KWAK J, Tiwari I, Jang KL
    Hepatitis C virus Core activates proteasomal activator 28 gamma expression via upregulation of p53 levels to control virus propagation.
    J Gen Virol. 2016 Nov 11. doi: 10.1099/jgv.0.000655.
    PubMed     Text format     Abstract available


  37. ZHANG H, Zhang J, Chen L, Weng Z, et al
    Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors.
    J Gen Virol. 2016 Nov 11. doi: 10.1099/jgv.0.000656.
    PubMed     Text format     Abstract available


  38. SMITH DB, Becher P, Bukh J, Gould EA, et al
    Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family.
    J Gen Virol. 2016;97:2894-2907.
    PubMed     Text format     Abstract available


    October 2016
  39. JIAO XY, Steenbergen RH, Tyrrell DL
    The use of human umbilical cord blood serum is beneficial for the continuous production of hepatitis C virus.
    J Gen Virol. 2016 Oct 24. doi: 10.1099/jgv.0.000636.
    PubMed     Text format     Abstract available


    September 2016
  40. WASILEWSKI L, Ray S, Bailey JR
    Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication competent virus and pseudoparticles.
    J Gen Virol. 2016 Sep 21. doi: 10.1099/jgv.0.000608.
    PubMed     Text format     Abstract available


  41. DU X, Pan T, Xu J, Zhang Y, et al
    Hepatitis C virus replicative double-stranded RNA is a potent interferon inducer that triggers interferon production through MDA5.
    J Gen Virol. 2016 Sep 16. doi: 10.1099/jgv.0.000607.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: